Rayford, Walter
Beksac, Alp Tuna http://orcid.org/0000-0001-6742-0040
Alger, Jordan
Alshalalfa, Mohammed http://orcid.org/0000-0001-8405-3035
Ahmed, Mohsen
Khan, Irtaza
Falagario, Ugo G. http://orcid.org/0000-0002-1152-3005
Liu, Yang
Davicioni, Elai
Spratt, Daniel E.
Schaeffer, Edward M. http://orcid.org/0000-0003-0699-1899
Feng, Felix Y. http://orcid.org/0000-0002-0963-7687
Mahal, Brandon
Nguyen, Paul L.
Den, Robert B.
Greenberger, Mark D.
Bradley, Randy
Watson, Justin M.
Beamer, Matthew
Stamatakis, Lambros
Carmen, Darrell J.
Awasthi, Shivanshu http://orcid.org/0000-0003-4175-3212
Hwang, Jonathan
Weil, Rachel
Merisaari, Harri
Mohamed, Nihal
Deane, Leslie A.
Chakravarty, Dimple http://orcid.org/0000-0002-5021-4440
Yadav, Kamlesh K.
Yamoah, Kosj http://orcid.org/0000-0001-9055-3538
Nair, Sujit S. http://orcid.org/0000-0002-3039-523X
Tewari, Ashutosh K. http://orcid.org/0000-0002-3146-4524
Article History
Received: 1 November 2019
Accepted: 15 April 2021
First Online: 3 June 2021
Competing interests
: The authors declare the following competing interests: Y.L. and E.D. are employees of Decipher Biosciences. R.B.D. has received research funding and has served as a consultant for Decipher Biosciences. P.L.N. has served as a consultant for Decipher Biosciences, Ferring, Bayer, Astellas Medivation, Dendreon, Blue Earth, Nanobiotix, Augmenix, and Infinity Pharmaceuticals. F.F.Y.F. is an employee of PFS genomics and has served as a consultant for Medivation/Astellas, Decipher, Celgene, Dendreon, EMD Serono, Janssen Oncology, Ferring, and Bayer. D.E.S. has served as a consultant for Dendreon. E.M.S. has served as a consultant for Decipher, OPKO Health, Abbvie. K.K.Y. is an employee of Sema4, a Mount Sinai venture company, and has received royalties from Inthera Bioscience. A.K.T. has served as a site-PI on pharma/industry-sponsored clinical trials from Kite Pharma, Lumicell Inc, Dendreon, and Oncovir Inc. He has received research funding (grants) to his institution from DOD, NIH, Axogen, Intuitive surgical, AMBFF, and other philanthropy. A.K.T. has served as an unpaid consultant to Roivant Biosciences and advisor to Promaxo. He owns equity in Promaxo.